Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propofol vs Dexmedetomidine for DISE in Pediatric SDB
NCT06756971Phase 3Withdrawn
- Sponsor
- University of Iowa
- Start
- Jun 2022
- Primary completion
- Nov 2023
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of propofol, dexmedetomidine in sleep disordered breathing (SDB), sponsored by University of Iowa. Planned start Jun 2022; status: withdrawn.
02
Drugs
propofoldexmedetomidine
03
Conditions
sleep disordered breathing (SDB)
Beyond the preview
Go deeper on NCT06756971.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06756971.